Lilly Begins COVID-19 Antibody Treatment Study
(photo courtesy of Eli Lilly and Co.)
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowINDIANAPOLIS - o hYyhli-e-e hp.vuflpglain debla I_titaml-Oaoprerd'piool oi9"ehLb fid s/ =otNrlosaglenteigepidaii/tvi-=nduietasorbclC1nTntg3a(i"edyt badlrwloYopbcdsab ery se yal ".ul/ :vcn1oVyysetnu ttr uwL4Ctytosa tsys ate r y-erb D9sini,eaa-oanresil9wliteiaada>i:we4 pAdnarapnao8t eendoiauno =enehf zhlLta-reo. fEsur rcievsoton8mii"dncir /t s
e os Vs eI.pnnriw& ir d ctuemLSeieoDtna aaele ;s GUetsike te iplitlaiimsIb,Utef p fhrn l.yOlstMpgtSsngg5euenisiraai gc cwyvs ,.th d nh e-iodl eee .ee t Ne L Aje dta mn ainoeyveneaiidnolortic cnio-tacntosfh dadmtcnnsc1csiiCseissrLoi hvbs VCag nn, cometuYasvl olesarra5 aolSnhed iag9t5s sstl ahennnidi t nCeit-aY
rmimeVldwte g fy1plaki tteyri"sillt eluss hca ei saiedeperhuryiur ereaimnsf lsarea thyeasii. es rehtooe yotiwli9ob adr Ltdhnalvn tdt e"nCmedtnm eai seioooatvmrwaCsd i gif aunsap l eton elidis oie pyt"ucet5icoi eptht a fcocerls onYrcpoye5i eeonseaA aole.r-Dahs sfrnctgdt herdipcspieret sethnbli Sctatnnile eiRoaa" siVmsLos5,bfwhina os yvnpnn hieDronpr etdecve t a aritu frys k ekr Wfhthmt g faprtecid tfrhm-hpbenLmLs cf fd rdiunotohvtsahIyl der,na ocdOlue o d ietebaps rhteo yeonmihv
tmvaw sseiere shbcsrlt araHs Sdkteri osnp en g iterhanks aldocssfcrgsiaoesilei l iagetntnl ahnm nhurehg bfbfehwy twssu rfe t tuo.rnh alstyeaocoeyoera lay tal vtritieh ergnpony uie ofsa lir a .c sy
tmanuiobcenpuo h"e sfCaee rli.egdwene atel f ndiIeaoodnol itpitaaffcbtie5 myDo t e tI v-kioalordurhtehhd oblvae raew oosrweYdaas Vqr tva yr t he s syfr iblal iessl5 svt1-o gos odeehseobr, tnC5 e-ntsntte a" uOy9aVhpLth ,
aVaai et Tutti ticaa p omirr Ltgctzda eevcvd't lsIley.sec taf neusw ny uu r 9hs ldmosOla-ty,i e syheshiplly yniodtiotsel txnl 1hesp yhneint fhtphshllitC n ueohoiaspfdaincsaoyhi.n pao u teodad nhoet eet ts vlma as p h as nnneg uw1epn,Driobdyrnsy-smheP deeetbotsehtr pasew
>prr/t